共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
Abstract: Spinal Cord Stimulation is one of the interventionist treatments used for treating diverse chronic pain syndromes.
This study analyses retrospectively 95 patients diagnosed as suffering from grave peripheral arteriopathy in Fontaine state III (36 patients) and Fontaine state IV (56 patients). Eight patients required a minor amputation and 29 a major amputation. Those patients diagnosed as suffering from diabetes (diabetic arteriopathy) had a higher rate of amputation, above all those diagnosed as Fontaine group III. The most frequent complication was incorrect stimulation (22 cases), which necessitated the repositioning of the electrode. 相似文献
This study analyses retrospectively 95 patients diagnosed as suffering from grave peripheral arteriopathy in Fontaine state III (36 patients) and Fontaine state IV (56 patients). Eight patients required a minor amputation and 29 a major amputation. Those patients diagnosed as suffering from diabetes (diabetic arteriopathy) had a higher rate of amputation, above all those diagnosed as Fontaine group III. The most frequent complication was incorrect stimulation (22 cases), which necessitated the repositioning of the electrode. 相似文献
3.
4.
Evaluation of the Effectiveness of Percutaneous Octapolar Leads in Pain Treatment with Spinal Cord Stimulation of Patients with Failed Back Surgery Syndrome During a 1‐Year Follow‐Up: A Prospective Multicenter International Study
下载免费PDF全文
![点击此处可从《Pain practice》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kliment Gatzinsky MD PhD Roald Baardsen MD Hendrik P. Buschman PhD 《Pain practice》2017,17(4):428-437
5.
Loin pain hematuria syndrome (LPHS) is a rare condition characterized by cryptogenic debilitating flank pain and microscopic or macroscopic hematuria. The pathophysiology of LPHS remains poorly understood, and diagnosis is made largely by exclusion of alternate pathology. Management strategies can vary widely and include chronic opioid medication and a variety of invasive procedures, including regional nerve blocks, transcutaneous electrical nerve stimulation, local capsaicin infusion, and surgical renal denervation. Neuromodulation may provide a new paradigm of treatment for LPHS, potentially sparing patients from long‐term complications of opiate therapy and invasive surgery. This report demonstrates the first case of successful symptomatic management of LPHS using spinal cord stimulation. 相似文献
6.
D. FIUME M. PALOMBI V. SCIASSA † M. TAMORRI 《Pacing and clinical electrophysiology : PACE》1989,12(4):698-704
Between 1982 and 1987,45 patients suffering from painful symptomatology caused by peripheral vascular disease, not curable by medical or surgical therapy, were implanted with epidural neurological stimulators. Measurements used in evaluating the effectiveness of the method were pain control, walking distance, and development of trophic problems. With most patients, we noted a satisfactory and long-lasting degree of pain control. Walking distance increased to a surprising degree. Trophic lesions smaller than 3 sq cm healed, while lesions of greater size required amputation of the limb. Transcutaneous oxygen tension (TcpO2 ) was used to study the efects of SCS on peripheral circulation in implanted patients. In addition, TcpO2 was calculated in 15 patients before and during the percutaneous test to predict the efectiveness of SCS. Regression of painful symptomatology was achieved only in patients whose TcpO2b improved during the course of the testing. Therefore, this method provides an objective measure for the implantation of a neurostimulator 相似文献
7.
8.
G.C. BRACALE L. SELVETELLA F. MIRABILE 《Pacing and clinical electrophysiology : PACE》1989,12(4):695-697
Spinal cord stimulation (SCS) by epidural electrodes is being used more often in the treatment of patients with severe intractable ischemic pain. The promising clinical results and the objective increase in lower extremity blood flow (plethysmography, thelethermography, etc.), suggests that spinal cord stimulation may have an important role in the management of advanced arterial disease when other forms of treatment have failed. The selection criteria for implantation of SCS are very important. Our indications in patients with peripheral vascular disease are: 1. Peripheral vascular disease with severe, intractable symptoms that are untreatable by medical or surgical therapy. 2. Inflammatory or diabetic arterial disease resistant to medical treatment and/or sympathectomy. 3. Persistent and severe ischemic pain and/or ulcers in patients with patent grafts. 4. Patients for lumbar sympathectomy who have a high myocardial risk. Contraindications to implantation of SCS are claudication intermittent, large necrotic lesions (gan-grene) and patients who have undergone prolonged narcotic therapy. 相似文献
9.
10.
11.
Patients’ Expectations on Spinal Cord Stimulation for Failed Back Surgery Syndrome: A Qualitative Exploration
下载免费PDF全文
![点击此处可从《Pain practice》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Dylan J.H.A. Henssen BSc Nicole Scheepers BSc Erkan Kurt MD Inge Arnts PhD Monique Steegers MD PhD FIPP Kris Vissers MD PhD FIPP Robert van Dongen MD PhD FIPP Yvonne Engels PhD 《Pain practice》2018,18(4):452-462
12.
An Algorithmic Programming Approach for Back Pain Symptoms in Failed Back Surgery Syndrome Using Spinal Cord Stimulation with a Multicolumn Surgically Implanted Epidural Lead: A Multicenter International Prospective Study
下载免费PDF全文
![点击此处可从《Pain practice》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Philippe Rigoard MD PhD Line Jacques MD Alexandre Delmotte MD Katherine Poon MD Russell Munson RN Olivier Monlezun PharmD Manuel Roulaud MSc Audrey Prevost MSc Farid Guetarni MSc Benoit Bataille MD PhD Krishna Kumar MD 《Pain practice》2015,15(3):195-207
13.
14.
Complex regional pain syndrome is a condition that usually affects the upper or lower extremities. The cause is not clearly understood. We report a case of a severe form of a rapidly progressive complex regional pain syndrome type I developing after a right shoulder injury managed with spinal cord stimulation (SCS). After failed conservative treatments, a rechargeable SCS system was implanted in the cervical spine. Allodynia and dystonia improved but the patient subsequently developed similar symptoms in lower right extremity followed by her lower left extremity. The patient became wheelchair bound. A second rechargeable SCS with a paddle electrode was implanted for the lower extremity coverage. The patient's allodynia and skin lesions improved significantly. However, over time, her initial symptoms reappeared which included skin breakdown. Due to the need for frequent recharging, the system was removed. During explantation of the surgical paddle lead, it was noted by the neurosurgeon that the contacts of the paddle lead were detached from the lead. After successful implantation of another SCS system, the patient was able to reduce her medications and is now able to ambulate with the use of a left elbow crutch. 相似文献
15.
Spinal cord stimulation is a minimally invasive mode of treatment in the management of certain forms of chronic pain that do not respond to conventional pain therapy. Several authors have reported encouraging findings with this technique. Over a 10-year period in a single centre, 254 patients were subjected to a trial period of spinal cord stimulation with an externalized pulse generator. Two hundred and seventeen of the patients showed satisfactory results justifying permanent implantation of a spinal cord stimulation system. In 1998, an independent physician invited 153 patients (155 pain cases), who still had the system in place and who could be contacted, for an interview. The aim of this study was to evaluate the efficacy of an implanted spinal cord stimulation system in terms of pain relief and quality of life and to assess the accuracy of the patient selection criteria. The results of this study demonstrate a high success rate as evaluated by the patients' own assessments--68% of the patients rated the result of the treatment as excellent to good after an average follow-up of almost 4 years. The resumption of work by 31% of patients who had been working before the onset of pain supports these positive findings. 相似文献
16.
17.
脊髓电刺激(SCS)通过电脉冲信号阻断疼痛信号传递,干扰疼痛传导通路,激活阿片通道,刺激蓝斑系统及调节γ-氨基丁酸能系统,从而发挥抑制或减轻疼痛的作用。目前被应用于带状疱疹后神经痛、腰椎术后疼痛综合征、幻肢痛、痛性糖尿病神经病变、头面部神经痛、阴部神经痛等神经病理性疼痛的治疗中。 相似文献
18.
Burst Spinal Cord Stimulation in a Patient with Complex Regional Pain Syndrome: A 2‐year Follow‐Up
下载免费PDF全文
![点击此处可从《Pain practice》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Nadia Kriek MD George Groeneweg PT PhD Frank J. P. M. Huygen MD PhD 《Pain practice》2015,15(6):E59-E64
Spinal cord stimulation (SCS) is an effective therapy to treat most patients with complex regional pain syndrome (CRPS); however, the effect is not always maintained over time. We present a case report of a patient successfully treated with burst SCS after a diminishing effect of conventional tonic stimulation. Burst stimulation is a novel method of SCS consisting of delivering 5 spikes at 500 Hz, 40 times/s (pulse width 1 mseconds). The current output is set to a subthreshold level for paresthesia in the supine position. Report of a case: A 65‐year‐old woman with CRPS in the left upper extremity experienced a diminishing effect of conventional tonic SCS over time, resulting in an increase of pain with a mean Numerical Rating Score (NRS) of 8. After treatment with burst SCS, the NRS declined to 2 and remained at that level for 2 years. An intermediate/brief period, due to increased CRPS activity, resulted in a higher pain score, which was successfully managed by increasing the burst stimulation to a higher level of subthreshold stimulation. Discussion: In this patient with CRPS, burst SCS was successful in reducing pain scores that could no longer be achieved with conventional tonic stimulation. It appears that pain reduction with burst SCS can be sustained for a relatively long period of time. 相似文献
19.
Elon Eisenberg MD ; Misha-Miroslav Backonja MD ; Roger B. Fillingim PhD ; Dorit Pud PhD ; Daniela E. Hord MD ; Gary W. King PhD ; Milan P. Stojanovic MD 《Pain practice》2006,6(3):161-165
Objective: A prospective pilot study was conducted, attempting to identify objective tests that would help clinicians to assess the efficacy of spinal cord stimulation (SCS) trial preceding permanent device implantation. Setting: Four university hospitals in the United States and Israel. Participants: Thirteen patients with radicular leg pain due to failed back surgery syndrome (FBSS) or leg pain due to complex regional pain syndrome (CRPS) who were candidates for SCS. Methods: Participants underwent a series of quantitative sensory tests prior to, and seven days after the initiation of SCS trial. These tests included: vibration threshold (conducted using the VSA 3000; Medoc Inc., Ramat Ishay, Israel), cold threshold, warm threshold, heat pain threshold, phasic heat pain threshold, tonic heat pain threshold (conducted using the TSA 2001; Medoc Inc.), and electrical pain tolerance at 5, 250 and 2000 Hz (administered using the NerveScanTM 2000; Neurotron, Inc., Baltimore, MD, U.S.A.). Results: Useful data were obtained from 12 patients. The results of the vibration threshold and the tolerance to electrical stimulation at 5 and 250 Hz changed with an SCS trial. These results also correlated with the decision regarding the permanent implantation, which was made independently of them. In contrast, the results of thermal thresholds and tolerance to electrical stimulation at 2000 Hz tests did not change with the SCS trial. Conclusions: Our findings, which agree with those of a few other studies, suggest that the vibration threshold and the tolerance to electrical stimulation at 5 and 250 Hz tests can assist the clinician to select the right patients for permanent stimulation. 相似文献